Last reviewed · How we verify

NCT06823141

Effect of Virtual Reality Immersion on Patient's Anxiety During Pre-oxygenation Before General Anaesthesia

Completed NA Last updated 30 September 2025
What this trial tests

NA trial testing Virtual reality immersion in Virtual Reality in 46 participants. Completed in 9 September 2025.

Timeline
24 January 2025
Primary endpoint
9 September 2025
9 September 2025

Quick facts

Lead sponsorEnte Ospedaliero Cantonale, Bellinzona
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment46
Start date24 January 2025
Primary completion9 September 2025
Estimated completion9 September 2025
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Ente Ospedaliero Cantonale, Bellinzona — full company profile →

Who can join

18 and older, any sex, with Virtual Reality or Pre-oxygenation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn if the use of virtual reality immersion during pre-oxygenation before general anesthesia could be feasible and beneficial for the patient. The main questions it aims to answer are: Does virtual reality immersion during pre-oxygenation reduce patient's anxiety? Does it impact patient's and anaesthetist's comfort? Is this technique easy to implement?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

Other Ente Ospedaliero Cantonale, Bellinzona trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06823141.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing